Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,764,500 | 1,745,000 | 820,200 | 2,941,600 | 2,058,980 |
| Depreciation Amortization | 444,100 | 292,500 | 147,900 | 688,100 | 530,508 |
| Income taxes - deferred | -185,800 | -90,600 | 16,700 | -308,200 | -229,273 |
| Accounts receivable | -63,600 | -38,900 | -128,300 | -512,400 | -297,057 |
| Other Working Capital | -510,200 | -254,500 | -271,000 | -484,400 | -374,760 |
| Other Operating Activity | 226,700 | 126,800 | 147,500 | 617,400 | 320,854 |
| Operating Cash Flow | $2,675,700 | $1,780,300 | $733,000 | $2,942,100 | $2,009,252 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -456,900 | -227,700 | -97,800 | -287,800 | -180,854 |
| Net Acquisitions | -748,800 | -448,800 | -448,800 | -375,000 | -175,000 |
| Purchase Of Investment | -4,870,100 | -2,045,000 | -323,000 | -3,583,100 | -2,738,584 |
| Sale Of Investment | 3,363,400 | 975,500 | 373,600 | 2,718,900 | 1,942,871 |
| Purchase Sale Intangibles | -6,300 | N/A | N/A | -28,200 | N/A |
| Other Investing Activity | -33,700 | -10,100 | -6,800 | -16,000 | -13,131 |
| Investing Cash Flow | $-2,746,100 | $-1,756,100 | $-502,800 | $-1,543,000 | $-1,164,698 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,930,900 | N/A | N/A | N/A | N/A |
| Debt Repayment | -2,100 | N/A | N/A | -2,700 | -2,674 |
| Common Stock Issued | 45,500 | 34,700 | 25,600 | 54,900 | 44,960 |
| Common Stock Repurchased | -2,998,200 | -42,200 | N/A | -886,800 | -359,981 |
| Other Financing Activity | 8,700 | 84,700 | 55,200 | 78,700 | 75,087 |
| Financing Cash Flow | $2,984,800 | $77,200 | $80,800 | $-755,900 | $-242,608 |
| Exchange Rate Effect | -30,300 | -24,200 | -37,800 | -40,900 | -18,227 |
| Beginning Cash Position | 1,204,900 | 1,204,900 | 1,204,900 | 602,600 | 602,562 |
| End Cash Position | 4,089,000 | 1,282,100 | 1,478,100 | 1,204,900 | 1,186,281 |
| Net Cash Flow | $2,884,100 | $77,200 | $273,200 | $602,300 | $583,719 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,675,700 | 1,780,300 | 733,000 | 2,942,100 | 2,009,252 |
| Capital Expenditure | -456,900 | -227,700 | -97,800 | -287,800 | -180,854 |
| Free Cash Flow | 2,218,800 | 1,552,600 | 635,200 | 2,654,300 | 1,828,398 |